HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duchateau, P. N. Articles by Malloy, M. J. Search for Related Content PubMed PubMed Citation Articles by Duchateau, P. N. Articles by Malloy, M. J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 41, 1231-1236, August 2000
Copyright © 2000 by Lipid Research, Inc.

Original Article

Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects

Correspondence to: Philippe N. Duchateau

Apolipoprotein L is a newly recognized component of human plasma lipoproteins. Mainly associated with apoA-I-containing lipoproteins, it is a marker of distinct HDL subpopulations. In an effort to gain inference as to its as yet unknown function, we studied biological determinants of apoL levels in human plasma. The distribution of apoL in normal subjects is asymmetric, with marked skewing toward higher values. No difference was found in apoL concentrations between males and females, but we observed an elevation of apoL in primary hypercholesterolemia (10.1 vs. 8.5 µg/mL in control), in endogenous hypertriglyceridemia (13.8 µg/mL, P < 0.001), combined hyperlipidemia phenotype (18.7 g/mL, P < 0.0001), and in patients with type II diabetes (16.2 µg/mL, P < 0.02) who were hyperlipidemic.

Significant positive correlations were observed between apoL and the log of plasma triglycerides in normolipidemia (0.446, P < 0.0001), endogenous hypertriglyceridemia (0.435, P < 0.01), primary hypercholesterolemia (0.66, P < 0.02), combined hyperlipidemia (0.396, P < 0.04), hypo-alphalipoproteinemia (0.701, P < 0.005), and type II diabetes with hyperlipidemia (0.602, P < 0.01). Apolipoprotein L levels were also correlated with total cholesterol in normolipidemia (0.257, P < 0.004), endogenous hypertriglyceridemia (0.446, P = 0.001), and non-insulin-dependent diabetes mellitus (NIDDM) (0.548, P < 0.02). No significant correlation was found between apoL and body mass index, age, sex, HDL-cholesterol or fasting glucose and glycohemoglobin levels. ApoL levels in plasma of patients with primary cholesteryl ester transfer protein deficiency significantly increased (7.1 ± 0.5 vs. 5.47 ± 0.27, P < 0.006).—Duchateau, P. N., I. Movsesyan, S. Yamashita, N. Sakai, K-I. Hirano, S. A. Schoenhaus, P. M. O'Connor-Kearns, S. J. Spencer, R. B. Jaffe, R. F. Redberg, B. Y. Ishida, Y. Matsuzawa, J. P. Kane, and M. J. Malloy. Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J. Lipid Res. 2000. 41: 1231;–1236.

Supplementary key words: apolipoprotein L, triglycerides, hypercholesterolemia, hypertriglyceridemia, combined hyperlipidemia, diabetes, CETP deficiency

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Gangadharan, R. Antrobus, R. A. Dwek, and N. Zitzmann Novel Serum Biomarker Candidates for Liver Fibrosis in Hepatitis C Patients Clin. Chem., October 1, 2007; 53(10): 1792 - 1799. [Abstract] [Full Text] [PDF]

				T. S. E. Albert, P. N. Duchateau, S. S. Deeb, C. R. Pullinger, M. H. Cho, D. C. Heilbron, M. J. Malloy, J. P. Kane, and B. G. Brown Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL J. Lipid Res., March 1, 2005; 46(3): 469 - 474. [Abstract] [Full Text] [PDF]

				P. N. Duchateau, C. R. Pullinger, M. H. Cho, C. Eng, and J. P. Kane Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene J. Lipid Res., April 1, 2001; 42(4): 620 - 630. [Abstract] [Full Text]